eyesON | Decentralized Clinical Trials Outlook: USA
Explore clinical trial and enrollment activity across countries with ease. Our new eyesON application visualizes data from ClinicalTrials.gov, helping you gain a deeper understanding.
Training Implications of the ICH E6(R3) and E8(R1) Guidelines
Be prepared for ICH E6(R3): turn guidelines into real-world action. In this post, we delve into the key updates and training gaps.
A Comparative Review of the ICH E6(R3) and E8(R1) Guidelines
Unpacking the new ICH guidelines, E6(R3) and E8(R1), we illuminate their key elements, identify gaps, and compare the two in terms of their unity, differences, and complementarity.
Embracing the Future: FDA’s New Draft Guidance on Decentralized Clinical Trials
Dive into the FDA's latest draft guidance on Decentralized Clinical Trials and the role of Risk-Based Quality Management. Learn how RBQM and centralized monitoring can elevate your clinical research efficiency and reliability.
Big Pharma M&As: Is It Worth the Trouble?
Big Pharma M&As: A Worthwhile Challenge? Navigating the complex landscape of M&As in the pharmaceutical industry comes with unique objectives and potential benefits. But do these transactions truly drive shareholder value for the acquiring firm?
Enhancing R&D Due Diligence in Pharma M&As: The Role of MyRBQM Portal
Navigate your M&A journey confidently with Cyntegrity's MyRBQM Portal. Aspiring to hit your targets within 6-12 months? Discover how we can make it possible in R&D due diligence.
eyesON | Big Pharma M&As: Clinical Trials Data Visualization
Explore clinical trial and enrollment activity across countries with ease. Our new eyesON application visualizes data from ClinicalTrials.gov, helping you gain a deeper understanding.
Global Impact of COVID-19 Pandemic on Clinical Trials
Wondering how the COVID-19 pandemic has impacted clinical trials worldwide? The COVID-19 pandemic has brought unprecedented challenges to the healthcare industry worldwide. The clinical trial sector has been no exception, and it has [...]
Cyntegrity Unveils Online Learning: Empowering Clinical Trial Professionals
We're excited to announce the launch of Cyntegrity's new online learning platform, MyRBQM Academy. As a pioneer in providing intelligent RBQM technology solutions, we believe that education is the first step in transitioning to a new way of working in clinical research.
FDA releases updated guidelines for risk-based approaches to monitoring
FDA Guidance: A Risk-Based Approach to Monitoring of Clinical Investigations (Q&A) The FDA has published a new guidance document titled "A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers Guidance for [...]
eyesON | COVID-19: Global Impact on Clinical Trials
Explore clinical trial and enrollment activity across countries with ease. Our new eyesON application visualizes data from ClinicalTrials.gov, helping you gain a deeper understanding.
Revolutionizing Clinical Data Management in the US: A Look at the Past, Present, and Future
Discover how clinical data management in the US has transformed from data collection to a multi-faceted endeavor, driving breakthroughs in biomedical research, diagnostics, drug development, and vaccines. Learn from leading experts, including our Chief Scientific Officer, about the latest advancements and future prospects in this groundbreaking publication.